Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-22

Clinical Trial Update: An International Pulmonary Embolism Registry Using EKOS

View source ↗

Summary

Completed international registry study evaluating EKOS for pulmonary embolism with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EKOS

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Pulmonary Embolism and Thrombosis | Status: COMPLETED | Results posted: 2023-02-22